96
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Genistein treatment increases bone mass in obese, hyperglycemic mice

, , &
Pages 63-70 | Published online: 15 Mar 2016

Figures & data

Figure 1 The effects of genistein treatment on body mass and serum glucose in ob/ob mice.

Notes: There was no difference between control and genistein-fed mice in body mass (50.9±2.1 g and 46.3±1.2 g, respectively, P=0.06) or serum glucose in control (465.1±22.1 mg/dL and 408.7±37.5 mg/dL, respectively, P=0.22). Data are shown as mean ± 2 SE.
Abbreviation: SE, standard error.
Figure 1 The effects of genistein treatment on body mass and serum glucose in ob/ob mice.

Table 1 The effects of genistein treatment on cross-sectional geometric properties of the tibial midshaft in ob/ob mice

Figure 2 Micrographs of the proximal tibial growth plate of (A) control and (B) genistein-fed ob/ob mice.

Notes: Scale bar is 100 μm. Toluidine blue and aqueous fast green stains were used, 40× magnification.
Figure 2 Micrographs of the proximal tibial growth plate of (A) control and (B) genistein-fed ob/ob mice.

Figure 3 Growth plate thickness in control and genistein fed mice.

Notes: Growth plate thickness was significantly reduced in genistein-treated mice (42.7±1.98 μm) in comparison with controls (49.3±1.96 μm, P=0.03). There was no difference in the thickness of the calcified cartilage layer between genistein treated (18.6±1.16 μm) and control mice (21.0 ± 1.14 μm, P=0.20). Data are shown as mean ± 2 SE.
Abbreviation: SE, standard error.
Figure 3 Growth plate thickness in control and genistein fed mice.